JP2013530719A5 - - Google Patents

Download PDF

Info

Publication number
JP2013530719A5
JP2013530719A5 JP2013520127A JP2013520127A JP2013530719A5 JP 2013530719 A5 JP2013530719 A5 JP 2013530719A5 JP 2013520127 A JP2013520127 A JP 2013520127A JP 2013520127 A JP2013520127 A JP 2013520127A JP 2013530719 A5 JP2013530719 A5 JP 2013530719A5
Authority
JP
Japan
Prior art keywords
galactosyl
enzyme
amino acid
acid sequence
donor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013520127A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013530719A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2011/062355 external-priority patent/WO2012010597A1/en
Publication of JP2013530719A publication Critical patent/JP2013530719A/ja
Publication of JP2013530719A5 publication Critical patent/JP2013530719A5/ja
Pending legal-status Critical Current

Links

JP2013520127A 2010-07-19 2011-07-19 ガラクトオリゴ糖含有組成物およびそれを生産する方法 Pending JP2013530719A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US36556010P 2010-07-19 2010-07-19
EP10169981.7 2010-07-19
EP10169981 2010-07-19
US61/365,560 2010-07-19
PCT/EP2011/062355 WO2012010597A1 (en) 2010-07-19 2011-07-19 Galacto-oligosaccharide-containing composition and a method of producing it

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016184955A Division JP2017018135A (ja) 2010-07-19 2016-09-22 ガラクトオリゴ糖含有組成物およびそれを生産する方法

Publications (2)

Publication Number Publication Date
JP2013530719A JP2013530719A (ja) 2013-08-01
JP2013530719A5 true JP2013530719A5 (cg-RX-API-DMAC7.html) 2014-08-28

Family

ID=43218466

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013520127A Pending JP2013530719A (ja) 2010-07-19 2011-07-19 ガラクトオリゴ糖含有組成物およびそれを生産する方法

Country Status (13)

Country Link
US (2) US20130189746A1 (cg-RX-API-DMAC7.html)
EP (1) EP2596113B1 (cg-RX-API-DMAC7.html)
JP (1) JP2013530719A (cg-RX-API-DMAC7.html)
KR (1) KR20130041953A (cg-RX-API-DMAC7.html)
CN (1) CN103080329B (cg-RX-API-DMAC7.html)
AR (1) AR082261A1 (cg-RX-API-DMAC7.html)
BR (1) BR112013001109A2 (cg-RX-API-DMAC7.html)
CA (1) CA2805997A1 (cg-RX-API-DMAC7.html)
DK (1) DK2596113T3 (cg-RX-API-DMAC7.html)
EA (1) EA201300150A1 (cg-RX-API-DMAC7.html)
MX (1) MX348325B (cg-RX-API-DMAC7.html)
NZ (1) NZ607149A (cg-RX-API-DMAC7.html)
WO (1) WO2012010597A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2620506A1 (en) 2012-01-25 2013-07-31 Arla Foods Amba Method of producing a galacto-oligosaccharide-containing composition
EP3473714B1 (en) * 2012-06-08 2022-04-06 DuPont Nutrition Biosciences ApS Polypeptides having transgalactosylating activity
WO2013190530A1 (en) * 2012-06-22 2013-12-27 Glycom A/S Modified galactooligosaccharides
CA2913393A1 (en) 2013-05-24 2014-11-27 General Mills, Inc. Food products with yogurt whey
WO2015086746A1 (en) 2013-12-11 2015-06-18 Dupont Nutrition Biosciences Aps A method for preparing a dairy product having a stable content of galacto-oligosaccharide(s)
KR101595014B1 (ko) 2014-02-21 2016-02-18 재단법인 임실치즈과학연구소 갈락토올리고당 생성 유산균주를 이용한 발효유의 제조방법
EP3915384A1 (en) 2014-11-07 2021-12-01 DuPont Nutrition Biosciences ApS Recombinant host cell expressing beta-galactosidase and/or transgalactosylating activity deficient in cellulase
JP6851967B2 (ja) * 2014-11-07 2021-03-31 デュポン ニュートリション バイオサイエンシス エーピーエス トランスガラクトシル化活性を有する酵素を用いてガラクトースとフルクトース部分とを含むサッカリドを生成する方法
DK3607097T3 (da) 2017-04-07 2023-09-18 Dupont Nutrition Biosci Aps Bacillus-værtsceller, der danner beta-galactosidaser og lactaser i fravær af p-nitrobenzylesterase-sideaktivitet
GB201805577D0 (en) * 2018-04-04 2018-05-16 Optibiotix Health Ltd Prebiotic compositions and methods of production thereof
WO2023055902A1 (en) 2021-09-30 2023-04-06 Dupont Nutrition Biosciences Aps Method for reducing sugar in food stuff
US20250000113A1 (en) 2021-11-12 2025-01-02 Kerry Group Services International Ltd Method for producing a dairy product
AU2024242918A1 (en) 2023-03-29 2025-09-18 Danisco Us Inc. Methods for modifying texture in foodstuff via preferably in situ produced alpha-glucan

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1283876B1 (en) * 2000-05-26 2007-01-24 Arla Foods amba Beta-galactosidase isolated from bifidobacterium
EP1205555A1 (de) * 2000-11-08 2002-05-15 Solvent Innovation GmbH Enzymkatalyse in Gegenwart ionischer Flüssigkeiten
MXPA05010349A (es) * 2003-06-30 2006-03-08 Clasado Inc Composicion novedosa de galactooligosacaridos y preparacion de la misma.
GB0522740D0 (en) * 2005-11-08 2005-12-14 Clasado Inc Process for the production of oligosaccharides

Similar Documents

Publication Publication Date Title
JP2013530719A5 (cg-RX-API-DMAC7.html)
US12133899B2 (en) Coronavirus vaccine
JP7390349B2 (ja) 病的石灰化状態を治療するための組成物およびそれを使用する方法
EP3177723B1 (en) Aptamers for use against autoantibody-associated diseases
JP2015508291A5 (cg-RX-API-DMAC7.html)
RU2013155452A (ru) СПОСОБ ПОЛУЧЕНИЯ МОЛОЧНЫХ ОЛИГОСАХАРИДОВ ЧЕЛОВЕКА (HMOs) ИЛИ ИХ ПРЕДШЕСТВЕННИКОВ
JP2009521908A5 (cg-RX-API-DMAC7.html)
WO2010037836A3 (en) Cross-species-specific psmaxcd3 bispecific single chain antibody
JP2017510274A5 (cg-RX-API-DMAC7.html)
PH12013501927A1 (en) Nutritional compositions comprising alpha-hydroxyisocaproic acid
RU2012105308A (ru) Композиции белка f rsv и способы их получения
DE602007005496D1 (de) Ezymatisches verfahren zur herstellung von 2-o-glyceryl-alpha-d-glucopyranosid
TW202333780A (zh) 冠狀病毒疫苗
JP2013503110A5 (cg-RX-API-DMAC7.html)
TW200914615A (en) Formulation of sugar solutions for continuous ultracentrifugation for virus purification
JP2010077130A5 (cg-RX-API-DMAC7.html)
NZ571807A (en) Fat accumulation inhibitor
JP2015188432A5 (cg-RX-API-DMAC7.html)
AU2017323868A1 (en) Lysine specific histone demethylase-1 inhibitors and uses therefor
EP3936147A1 (en) Method for preparing influenza ha split vaccine
EP2091611A2 (fr) Nouveau médicament pour le traitement d'un cancer gastrique
US20230313325A1 (en) Methods for detection of pathogenic infections using red blood cell-containing patient samples
TW201546129A (zh) 油水分離方法
JP2017533713A5 (cg-RX-API-DMAC7.html)
Hoshi et al. Methylmercury causes neuronal cell death via M1-microglial activation in organotypic slices prepared from mouse cerebral cortex